These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32242850)

  • 21. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary Artery Bypass Grafting Versus Drug-Eluting Stents Implantation for Previous Myocardial Infarction.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Zeng Y; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    Am J Cardiol; 2016 Jul; 118(1):17-22. PubMed ID: 27181565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery.
    Razzouk L; Feit F; Farkouh ME
    Curr Cardiol Rep; 2017 May; 19(5):37. PubMed ID: 28374179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers for risk stratification in secondary cardiovascular prevention. A role of red blood cell distribution width and calcium score.
    Oleksiak A; Kruk M; Lenarczyk E; Pawelec M; Rajska E; Wilkońska P; Dzielińska Z; Demkow M; Witkowski A; Pręgowski J; Kępka C; Rużyłło W
    Atherosclerosis; 2016 Mar; 246():57-62. PubMed ID: 26756971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease: Incidence, Determinants, and Outcome (From the CORONOR Study).
    Hamon M; Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    JACC Cardiovasc Interv; 2018 May; 11(9):868-875. PubMed ID: 29747917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Left Ventricular Systolic Dysfunction: A Meta-Analysis.
    Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M; Zhang M
    Angiology; 2017 Jan; 68(1):19-28. PubMed ID: 27069109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the optimal revascularization technique for isolated disease of the left anterior descending artery: minimally invasive direct coronary artery bypass or percutaneous coronary intervention?
    Patel AJ; Yates MT; Soppa GK
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):144-8. PubMed ID: 24667582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
    Kumbhani DJ; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Deedwania P; Grau-Sepulveda M; Schwamm LH; Bhatt DL;
    Am J Med; 2015 Apr; 128(4):426.e1-9. PubMed ID: 25433302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year clinical and angiographic results of hybrid coronary revascularization.
    Modrau IS; Holm NR; Mæng M; Bøtker HE; Christiansen EH; Kristensen SD; Lassen JF; Thuesen L; Nielsen PH;
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1181-6. PubMed ID: 26432721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery Trial and Registry.
    Parasca CA; Head SJ; Mohr FW; Mack MJ; Morice MC; Holmes DR; Feldman TE; Colombo A; Dawkins KD; Serruys PW; Kappetein AP;
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):597-606.e2. PubMed ID: 26055439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.
    Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention.
    Wu JR; Leu HB; Yin WH; Tseng WK; Wu YW; Lin TH; Yeh HI; Chang KC; Wang JH; Wu CC; Chen JW
    Sci Rep; 2019 Feb; 9(1):3091. PubMed ID: 30816213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revascularization for Coronary Artery Disease: Principle and Challenges.
    Gu D; Qu J; Zhang H; Zheng Z
    Adv Exp Med Biol; 2020; 1177():75-100. PubMed ID: 32246444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact.
    Bauters C; Tricot O; Lemesle G; Meurice T; Hennebert O; Farnier M; Lamblin N
    Arch Cardiovasc Dis; 2018 Nov; 111(11):634-643. PubMed ID: 29198936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
    Kosmidou I; Redfors B; Chen S; Crowley A; Lembo NJ; Karmpaliotis D; Brown WM; Maupas E; Durrleman N; Shah A; Reardon MJ; Dressler O; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Am Heart J; 2019 Apr; 210():49-57. PubMed ID: 30738244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.